Capital Raising and Healthcare Investment Post-COVID

This chapter explores the challenges of securing investment during the bear market of 2022, with insights from the speaker's personal experiences. It analyzes the evolving healthcare landscape post-COVID, particularly the rise of mRNA technology and weight loss treatments, alongside the volatility of pharmaceutical company valuations. The discussion emphasizes the importance of long-term growth strategies in the wake of temporary revenue spikes from pandemic-related opportunities.